Skip to main content

Alphabet

By Laura Lovett | 05:30 pm | June 20, 2018
In a recent review, an independent group of panelists raised questions about UK-based AI company DeepMind’s business model, relationship with parent company Alphabet, and potential to monopolize its industry.
By Laura Lovett | 03:16 pm | June 08, 2018
The road to digital innovation in the pharma and healthcare space is going to take players across industries — from tech developers and engineers to researchers and clinicians, according to a panel of digital-focused VPs speaking at BIO 2018 in Boston.
By Jonah Comstock | 04:05 pm | May 24, 2018
Correction: A previous version of this story misstated the funding amount.
By Dave Muoio | 01:57 pm | February 22, 2018
The Department of Veterans Affairs has announced a research partnership with Alphabet subsidiary DeepMind that will tackle issues concerning patient deterioration during hospital care.
By Jonah Comstock | 05:44 pm | January 04, 2018
Cityblock Health, the urban-focused public health startup that spun out of Alphabet’s Sidewalk Labs in October, has raised $20.
By Heather Mack | 01:31 am | January 18, 2017
A new kind of doctor’s office opened in San Francisco this week: Forward, a membership-based healthcare startup founded by former Googler Adrian Aoun that infuses a brick-and-mortar office with data-driven technology and artificial intelligence.
By Jonah Comstock | 03:45 pm | January 11, 2016
Google has filed another interesting healthcare-related patent, a mechanism that could detect when a patient is eating and issue a contextual reminder to take a medication.
By Jonah Comstock | 06:18 pm | December 07, 2015
Google Life Sciences has finally gotten its new name as an independent company under the aegis of Alphabet: Verily.
By Aditi Pai | 12:13 pm | September 17, 2015
Google subsidiary Alphabet, has hired Dr.
By Jonah Comstock | 09:38 am | September 08, 2015
Google and Novartis are working on two smart contact lenses, and news broke this week about both of them: A new patent application sheds light on how Google might power its glucose-sensing contact lens, just a week after partner Novartis told a Swiss newspaper it was on track for human trials in 2016 of an autofocus lens for presbyopia patients.